Low frequency of p57(KIP2) mutation in Beckwith-Wiedemann syndrome

American Journal of Human Genetics

Volumn 61, Issue 2, 1997, Pages 304-309

  Lee, Maxwell P ^a   DeBaun, Michael ^b   Randhawa, Gurvaneet ^a   Reichard, Betty A ^a   Elledge, Stephen J ^c   Feinberg, Andrew P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; DNA; GLUTAMINE; NUCLEOTIDE; PROLINE; SOMATOMEDIN B; THREONINE; CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYTIDYLYL 3' 5' GUANOSINE; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; KCNQ1 PROTEIN, HUMAN; NUCLEAR PROTEIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL KCNQ1; VOLTAGE GATED POTASSIUM CHANNEL;

ALLELE; ARTICLE; BECKWITH WIEDEMANN SYNDROME; CANCER SUSCEPTIBILITY; CHROMOSOME 11P; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; EXON; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENE STRUCTURE; GENETIC LINKAGE; HUMAN; HUMAN CELL; INTRON; METHYLATION; NEPHROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; CHROMOSOME 11; CPG ISLAND; DNA METHYLATION; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETICS; GENOME IMPRINTING; INFANT; MALE; NUCLEOTIDE SEQUENCE; PEDIGREE;

BECKWITH-WIEDEMANN SYNDROME; CHROMOSOMES, HUMAN, PAIR 11; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYCLIN-DEPENDENT KINASES; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENETIC HETEROGENEITY; GENOMIC IMPRINTING; HUMANS; INFANT; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; MALE; NUCLEAR PROTEINS; PEDIGREE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 0030610261     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/514858     Document Type: Article

References (26)

1. Brown KW, Villar AJ, Bickmore W, Clayton-Smith J, Catchpoole D, Maher ER, Reik W (1996) Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum Mol Genet 5:2027-2032
2. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C (1993) Parental genomic imprinting of the human IGF2 gene. Nat Genet 4:98-101
3. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B (1993) Tumor-suppressor activity of H19 RNA. Nature 365:764-767
4. KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 14:171-173
5. Henry I, Bonaiti-Pellie C, Chehensse V, Beldjord C, Schwartz C, Utermann G, Junien C (1991) Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature 351:665-667
6. Jinno Y, Sengoku K, Nakao M, Tamate K, Miyamoto T, Matsuzaka T, Sutcliffe JS, et al (1996) Mouse/human sequence divergence in a region with a paternal-specific methylation imprint at the human H19 locus. Hum Mol Genet 5:1155-1161
7. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, et al (1989) Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719
8. Lee M-H, Reynisdottir I, Massague J (1995) Cloning of p57/ KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649
9. vLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements. Nat Genet 15:181-185
10. Mannens M, Hoovers JMN, Redeker E, Verjaal M, Feinberg AP, Little P, Boavida M, et al (1994) Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann Syndrome and various human neoplasia. Eur J Hum Genet 2:3-23
11. Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, et al (1995) p57/KIP2, a structurally distinct member of the p21/CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662
12. KIP2, on chromosome 11p15. Proc Natl Acad Sci USA 93:3026-3030
13. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, et al (1994) Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet 7:440-447
14. Ogawa O, Becroft DM, Morison IM, Eccles MR, Skeen JE, Mauger DC, Reeve AE (1993) Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism. Nat Genet 5:408-412
15. Ohlsson R, Nystrom A, Pfeifer-Ohlsson S, Tohonen V, Hedborg F, Schofield P, Flam F, et al (1993) IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet 4:94-97
16. Okano Y, Osasa Y, Yamamoto H, Hase Y, Tsuruhara T, Fujita H (1986) An infant with Beckwith-Wiedemann syndrome and chromosomal duplication 11p13Xpter: correlation of symptoms between 11p trisomy and Beckwith-Wiedemann syndrome. Jpn J Hum Genet 31:365-372
17. Ping AJ, Reeve AE, Law DJ, Young MR, Boehnke M, Feinberg AP (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44:720-723
18. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, Feinberg AP (1993) Relaxation of imprinted genes in human cancer. Nature 362:747-749
19. Reik W, Brown KW, Schneid H, LeBouc Y, Bickmore W, Maher ER (1995) Imprinting mutations in the Beckwith-Wiedemann syndrome suggested by an altered imprinting pattern in the IGF2-H19 domain. Hum Mol Genet 4:2379-2385
20. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, Feinberg AP (1994) Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nat Genet 7:433-439
21. KIP2 in Wilms tumor. Cancer Res 56: 5723-5727
22. KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet 97:625-631
23. Turleau C, de Grouchy J, Chavin-Colin F, Martelli H, Voyer M, Charlas R (1984) Trisomy 11p15 and Beckwith-Wiedemann syndrome: a report of two cases. Hum Genet 67:219-221
24. Waziri M, Patil SR, Hanson JW, Bartley JA (1983) Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J Pediatr 102:873-876
25. Weksberg R, Shen DR, Fei YL, Song QL, Squire J (1993) Disruption of insulin-like growth factor 2 imprinting in Beckwith-Weidemann syndrome. Nat Genet 5:143-150
26. Wiedemann HR (1983) Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129